Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03677869 · ClinicalTrials.gov registry record · NA

Effects of Pneumatic Vitreolysis on Macular Hole

A NA study of Vitreomacular Traction (VMT) and Full-thickness Macular Holes (MH), sponsored by Jaeb Center for Health Research.

Completed
Registry status
NA
Development phase
36
Enrollment target
20
Study locations

NCT03677869: Completed NA study of Vitreomacular Traction (VMT) and Full-thickness Macular Holes (MH), sponsored by Jaeb Center for Health Research.

NCT03677869 is a NA study of Vitreomacular Traction (VMT) and Full-thickness Macular Holes (MH) that has completed, run by Jaeb Center for Health Research. The registered enrollment target is 36 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 20 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03677869, a NA study of Vitreomacular Traction (VMT) and Full-thickness Macular Holes (MH), has completed, sponsored by Jaeb Center for Health Research.

COMPLETED
Registry status
NA
Development phase
36 participants
Enrollment target
20
Study locations

Study Summary

Eyes with vitreomacular traction (VMT) and full-thickness macular holes (MH) will be enrolled into a non-randomized cohort treated with pneumatic vitreolysis (PVL) to determine the proportion with VMT release and MH closure and to assess factors associated with success.

Conditions Studied

Vitreomacular Traction (VMT) Full-thickness Macular Holes (MH)

Interventions

  • DEVICE Intraocular gas (C3F8)

Study Locations (20)

Florida

  • National Ophthalmic Research Institute - Fort Myers
  • University of Florida College of Med., Dept of Ophthalmology, Jacksonville Hlth Sci Ctr - Jacksonville
  • Florida Retina Consultants - Lakeland
  • Florida Retina Institute - Orlando
  • Southeast Eye Institute, PA dba Eye Associates of Pinellas - Pinellas Park
  • Retina Associates of Sarasota - Sarasota
  • Sarasota Retina Institute - Sarasota

California

  • Retinal Diagnostic Center - Campbell
  • Atlantis Eye Care - Huntington Beach
  • Northern California Retina Vitreous Associates - Mountain View
  • East Bay Retina Consultants, Inc. - Oakland
  • Southern California Desert Retina Consultants, MC - Palm Desert

Illinois

  • Gailey Eye Clinic - Bloomington
  • University of Illinois at Chicago Medical Center - Chicago
  • Illinois Retina Associates, SC - Oak Park
  • Carle Foundation Hospital - Urbana

Georgia

  • Southeast Retina Center, PC - Augusta
  • Thomas Eye Group - Sandy Springs

Indiana

  • Raj K. Maturi, MD, PC - Indianapolis

Iowa

  • Wolfe Eye Clinic - West Des Moines

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2018-11-14
Est. Completion 2020-07-22
Phase NA
Jaeb Center for Health Research

119 total trials

What the finished NCT03677869 record still lists

NCT03677869 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 2 conditions, with Vitreomacular Traction (VMT) appearing as the primary indexed condition, and to 1 intervention - of which Intraocular gas (C3F8) is the first listed.

NCT03677869 names 20 study sites across 6 states, led by Florida, California, Illinois.

Frequently Asked Questions

What is clinical trial NCT03677869 about?

NCT03677869 is a clinical study titled "Effects of Pneumatic Vitreolysis on Macular Hole". Eyes with vitreomacular traction (VMT) and full-thickness macular holes (MH) will be enrolled into a non-randomized cohort treated with pneumatic vitreolysis (PVL) to determine the proportion with VMT release and MH closure and to assess factors associated with success.

What is the current status of trial NCT03677869?

This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2018-11-14. Estimated completion is 2020-07-22.

What conditions does trial NCT03677869 study?

This clinical trial studies the following conditions: Vitreomacular Traction (VMT), Full-thickness Macular Holes (MH).

What interventions are being tested in trial NCT03677869?

The interventions under investigation include: Intraocular gas (C3F8) (DEVICE).

Who is sponsoring clinical trial NCT03677869?

This trial is sponsored by Jaeb Center for Health Research, which has 119 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03677869 being conducted?

This trial has 20 study locations across California, Florida, Georgia, Illinois, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

How this trial's enrollment target compares

Where NCT03677869's enrollment target sits among peer trials

36 1541st of 2000 higher than 437 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00929006 · 36 participants · Early Phase 1

    Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism

  • NCT01891318 · 36 participants · Phase 1

    Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study

  • NCT02291848 · 36 participants · Phase 1

    Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma

  • NCT02366819 · 36 participants · Phase 4

    Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT03677869, the US trial registry maintained by the National Library of Medicine. NCT03677869 (small enrollment · wide site footprint · completed) retrieved and formatted by PlainTrial, see methodology.